Comparison timestamp: 2025-05-03 08:31:22 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/niosh-rtecs/MO1A8CE0.html
Live cdc.gov URL ↗: https://www.cdc.gov/niosh-rtecs/MO1A8CE0.html
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/niosh-rtecs/MO1A8CE0.html
Live cdc.gov URL ↗: https://www.cdc.gov/niosh-rtecs/MO1A8CE0.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected:
Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Original site: www.cdc.gov/niosh-rtecs/MO1A8CE0.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.[More]About Us Report Bug Compare ContentSkip directly to page optionsThe National Institute for Occupational Safety and Health (NIOSH)Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting PeopleSearchSearch Menu Navigation Menu× NIOSHNIOSH All CDCSubmit* Licensing Agreement Signed for RTECS* How Do I Access the RTECS Database?* Features of the RTECS Database* The National Institute for Occupational Safety and Health (NIOSH) HomeThe National Institute for Occupational Safety and Health (NIOSH)1. Registry of Toxic Effects of Chemical Substances (RTECS)Hexane, 1,6-diisocyanato-Related PagesRTECS #MO1740000CAS #822-06-0; 66368-96-5See: NMAM or OSHA MethodsUpdatedDecember 2018Molecular Weight168.22Molecular FormulaC8H12N2O2Synonyms1,6-Diisocyanatohexane1,6-Hexamethylene diisocyanate1,6-Hexanediol diisocyanateDesmodur HDesmodur NHDIHDI-ICHexamethylendiisokyanat (Czech)Hexamethylene diisocyanateHexamethylene diisocyanate (ACGIH)Hexamethylene-1,6-diisocyanateHMDIIsocyanic acid, diester with 1,6-hexanediolIsocyanic acid, hexamethylene esterMetyleno-bis-fenyloizocyjanian (Polish)Szesciometylenodwuizocyjanian (Polish)TL 78Acute Toxicity Data and ReferencesRoute/Organism Dose Effect ReferenceIn Vitro/Human, lung Inhibitor Concentration (20 percent kill): 1.1 mmol/L In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. TIVIEQ 30,274,2015In Vitro/Human, lung fibroblast Inhibitor Concentration Low: 95 µmol/L/6H In Vitro Toxicity Studies: Other assays TIVIEQ 28,209,2014In Vitro/Human, skin Inhibitor Concentration (20 percent kill): 40 mg/L/24H In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. TIVIEQ 27,1127,2013inhalation/mouse lethal concentration (50 percent kill): 30 mg/m3 85GMAT -,74,1982Eye: Lacrimationinhalation/rat Lowest published lethal concentration: 60 mg/m3/4H Lung, Thorax, or Respiration: Dyspnea GTPZAB 12(10),40,1968Nutritional and Gross Metabolic: Weight loss or decreased weight gaininhalation/rat lethal concentration (50 percent kill): 124 mg/m3/4H TOSCF2 58,173,2000Lung, Thorax, or Respiration: Changes in lung weightinhalation/rat lethal concentration (50 percent kill): 462 mg/m3/4H TOSCF2 58,173,2000Biochemical: Metabolism (intermediary): Other proteinsLung, Thorax, or Respiration: Other changesinhalation/rat lowest published toxic concentration: 15.9 mg/m3/6H TOSCF2 58,173,2000Nutritional and Gross Metabolic: Weight loss or decreased weight gainLung, Thorax, or Respiration: Consolidationinhalation/rat lowest published toxic concentration: 54.3 mg/m3/6H Lung, Thorax, or Respiration: Acute pulmonary edema TOSCF2 58,173,2000Lung, Thorax, or Respiration: Pleural effusioninhalation/rat lowest published toxic concentration: 118.1 mg/m3/6H TOSCF2 58,173,2000intravenous/mouse lethal dose (50 percent kill): 5600 µg/kg CSLNX* NX#07805oral/mouse lethal dose (50 percent kill): 350 mg/kg TAKHAA 39,202,1980oral/rat lethal dose (50 percent kill): 710 µL/kg AIHAAP 30,470,1969skin/rabbit lethal dose (50 percent kill): 570 µL/kg AIHAAP 30,470,1969Other Multiple Dose Data and ReferencesRoute/Organism Dose Effect Referenceinhalation/guinea pig lowest published toxic concentration: 1 ppm/6H/5D- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field NTIS** OTS0571057Nutritional and Gross Metabolic: Weight loss or decreased weight gaininhalation/mouse lowest published toxic concentration: 300 ppb/6H/5D- intermittent NTIS** OTS0571057Related to Chronic Data: Death in the "MULTIPLE DOSE" data type fieldImmunological Including Allergic: Increased immune responseinhalation/mouse lowest published toxic concentration: 7.5 mg/m3/3D- intermittent Biochemical: Metabolism (intermediary): Other proteins TXCYAC 261,103,2009Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammationinhalation/rat lowest published toxic concentration: 0.05 ppm/6H/28D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000inhalation/rat lowest published toxic concentration: 0.05 ppm/6H/47D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000inhalation/rat lowest published toxic concentration: 0.05 ppm/20D- continuous Olfaction: Other olfaction effects TJADAB 162,205,2000inhalation/rat lowest published toxic concentration: 50 ppb/6H/30D- intermittent Olfaction: Other olfaction effects REPTED 14,135,2000inhalation/rat lowest published toxic concentration: 2 ppm/6H/5D- intermittent Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field NTIS** OTS0571057Olfaction: Other olfaction effectsinhalation/rat lowest published toxic concentration: 40 ppb/6H/13W- intermittent NTIS** OTS0532755Eye: Conjunctiva irritationBehavioral: Convulsions or effect on seizure thresholdinhalation/rat lowest published toxic concentration: 30 ppm/4H/2W- intermittent Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi NTIS** OTS0555659Lung, Thorax, or Respiration: DyspneaGastrointestinal: Changes in structure or function of salivary glandsoral/rat lowest published toxic dose: 3 gm/kg/2W- intermittent Gastrointestinal: Hypermotility, diarrhea NTIS** OTS0555659Nutritional and Gross Metabolic: Weight loss or decreased weight gainImmunological Including Allergic: Increased immune responseskin/mouse lowest published toxic dose: 1 pph/3D- intermittent Biochemical: Metabolism (intermediary): Other proteins TXCYAC 261,103,2009Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammationReviewsOrganization Standard ReferenceAmerican Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value-time-weighted average 0.005 ppm DTLVS* TLV/BEI,2013TOXICOLOGY REVIEW TOLED5 140-141,213,2003TOXICOLOGY REVIEW FCTOD7 55,596,2013TOXICOLOGY REVIEW RTOPDW 55,43,2009Standards and RegulationsOrganization Standard ReferenceOccupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV;Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLVOccupational Exposure Limit-AUSTRALIA time-weighted average 0.02 mg(NCO)/m3, short term exposure limit 0.07 mg(NCO)/m3, JUL2008Occupational Exposure Limit-AUSTRIA MAK-TMW 0.005 ppm (0.035 mg/m3);KZW 0.005 ppm (0.035 mg/m3), sen, 2007Occupational Exposure Limit-BELGIUM time-weighted average 0.005 ppm (0.034 mg/m3), MAR2002Occupational Exposure Limit-DENMARK time-weighted average 0.005 ppm (0.035 mg/m3), MAY2011Occupational Exposure Limit-FRANCE VME 0.01 ppm (0.075 mg/m3), VLE 0.02 ppm (0.15 mg/m3), FEB2006Occupational Exposure Limit-GERMANY MAK 0.005 ppm (0.035 mg/m3), 2011Occupational Exposure Limit-HUNGARY time-weighted average 0.035 mg/m3, short term exposure limit 0.035 mg/m3, SEP2000Occupational Exposure Limit-ICELAND time-weighted average 0.005 ppm (0.03 mg/m3), short term exposure limit 0.01 ppm (0.07 mg/m3), sen, NOV2011Occupational Exposure Limit-JAPAN Occupational Exposure Limit 0.005 ppm (0.034 mg/m3), a1 sen, MAY2012Occupational Exposure Limit-NEW ZEALAND time-weighted average 0.02 mg(NCO)/m3; short term exposure limit 0.07 mg(NCO)/m3, sen, JAN2002Occupational Exposure Limit-PERU time-weighted average 0,005 ppm (0,034 mg/m3), JUL2005Occupational Exposure Limit-POLAND MAC(time-weighted average) 0.05 mg/m3, short term exposure limit 0.15 mg/m3, JAN1999Occupational Exposure Limit-RUSSIA short term exposure limit 0.05 mg/m3, Skin, JUN2003Occupational Exposure Limit-SWEDEN time-weighted average 0.002 ppm (0.02 mg/m3), ceiling concentration 0.005 ppm (0.03 mg/m3), Sen, JUN2005Occupational Exposure Limit-SWITZERLAND ceiling concentration 0.02 mg(NCO)/m3, skin, sen, JAN2011Occupational Exposure Limit-THE NETHERLANDS MAC-TGG 0.04 mg/m3, 2003NIOSH Documentation and SurveillanceOrganization Standard ReferenceNational Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO HDI-air 10H time-weighted average 0.035 mg/m3;ceiling concentration 0.14 mg/m3/10M NIOSH* DHHS #92-100,1992National Occupational Exposure Survey 1983 Hazard Code M4839; Number of Industries 21; Total Number of Facilities 1895; Number of Occupations 26; Total Number of Employees Exposed 19180; Total Number of Female Employees Exposed 329National Occupational Hazard Survey 1974 Hazard Code M4839; Number of Industries 9; Total Number of Facilities 238; Number of Occupations 12; Total Number of Employees Exposed 4490Status in Federal AgenciesOrganization ReferenceATSDR TOXICOLOGY PROFILE (NTIS** PB/99/102543/AS)EPA TSCA Section 8(b) CHEMICAL INVENTORYEPA TSCA Section 8(d) unpublished health/safety studiesEPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001NIOSH Analytical Method, 1994: Isocyanates, monomeric, 5521NIOSH Analytical Method, 1996: Isocyanates, 5522On EPA IRIS databaseOSHA ANALYTICAL METHOD #42Page last reviewed: November 16, 2018Content source: National Institute for Occupational Safety and Health* SyndicateRegistry of Toxic Effects of Chemical Substances (RTECS)* Licensing Agreement Signed for RTECS* How Do I Access the RTECS Database?* Features of the RTECS DatabaseFollow NIOSH* YouTubeNIOSH Homepage* Workplace Safety & Health Topics* Publications and Products* Programs* Contact NIOSH* About CDC* Contact Us* 800-232-4636Facebook Twitter Instagram LinkedIn Youtube Pinterest SnapchatFacebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat RSS* CONTACT CDCContact UsCall 800-232-4636Email Us* ABOUT CDC+ About CDC+ Jobs+ Funding* POLICIES+ Accessibility+ External Links+ Privacy+ Policies+ Web Policies+ No Fear Act+ FOIA+ OIG+ No Fear Act+ Nondiscrimination+ Vulnerability Disclosure Policy+ CDC Archive+ Public Health Publications+ HHS.gov+ USA.gov* CONNECT WITH US+ Youtube+ Snapchat* LANGUAGES+ Español+ 繁體中文+ Tiếng Việt+ 한국어+ Tagalog+ Русский+ العربية+ Kreyòl Ayisyen+ Français+ Polski+ Português+ Italiano+ Deutsch+ 日本語+ فارسی+ English* U.S. Department of Health & Human Services* Accessibility* External Links* Privacy* Policies* Web Policies* FOIA* OIG* No Fear Act* FOIA* Nondiscrimination* OIG* Vulnerability Disclosure Policy* CDC Archive* Public Health Publications* HHS.gov* USA.govContent Credential×This image was edited or created using GenAI (generative artificial intelligence).Our experts review all images in an effort to ensure accuracy and quality before use.Learn more about CDC's usage of GenAI.Exit Notification/Disclaimer PolicyCloseLinks with this icon indicate that you are leaving the CDC website.* The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.* Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.* You will be subject to the destination website's privacy policy when you follow the link.* CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.For more information on CDC's web notification policies, see Website Disclaimers.Cancel Continue
Note: Comparison ignores leading/trailing whitespace
and certain script/tracking codes. Word-level
highlighting (optional above) only applies to changed
lines.